Cargando…
Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia
Somatic mutations that lead to constitutive activation of NRAS and KRAS proto-oncogenes are among the most common in human cancer and frequently occur in acute myeloid leukemia (AML). An inducible NRAS(V12)-driven AML mouse model has established a critical role for continued NRAS(V12) expression in...
Autores principales: | Pomeroy, E J, Lee, L A, Lee, R D W, Schirm, D K, Temiz, N A, Ma, J, Gruber, T A, Diaz-Flores, E, Moriarity, B S, Downing, J R, Shannon, K M, Largaespada, D A, Eckfeldt, C E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464975/ https://www.ncbi.nlm.nih.gov/pubmed/27991934 http://dx.doi.org/10.1038/onc.2016.471 |
Ejemplares similares
-
RALB provides critical survival signals downstream of Ras in acute myeloid leukemia
por: Eckfeldt, Craig E., et al.
Publicado: (2016) -
Oncogene addiction and immune escape: friends or foes?
por: Abdayem, Pamela, et al.
Publicado: (2020) -
Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction
por: Ito, Reina E., et al.
Publicado: (2021) -
RalB directly triggers invasion downstream Ras by mobilizing the Wave complex
por: Zago, Giulia, et al.
Publicado: (2018) -
Oncogenic RAC1 and NRAS drive resistance to endoplasmic reticulum stress through MEK/ERK signalling
por: Bright, Michael D., et al.
Publicado: (2018)